For laboratory research only. Not for human consumption.Our comparison method ↗
deals on
peptidesSaved 0
Studio-style Deals on Peptides product visual for Sermorelin

Vial comparison

Sermorelin prices

Compare Sermorelin listings by strength, selection and supplier. Inspect the original source behind each price.

32suppliers represented
45source-linked listings
4strengths available
Other formatsSermorelin Atomized Solution Kit

MATCH SIZE AND QUANTITY

Build your comparison.

Daily snapshot · inspect sources

Choose a labeled amount and selection to load matching prices.

GO BEYOND THE PRICE

Track it. Plan it. Inspect it.

Select a strength and selection above to view price history, save a price watch or add it to your basket.

DOCUMENTATION PASSPORTS

Reports and batch records

Search all batch records

Inspect the source report, recorded lot and document access. A report link does not confirm the batch currently shipping.

Loading documentation records…

Listed amounts and selections

  • 2 mg1 supplier · Pack counts: 1
  • 5 mg16 suppliers · Pack counts: 1, 2, 3
  • 10 mg20 suppliers · Pack counts: 1, 3, 5, 10
  • 13 mg1 supplier · Pack counts: 1

Reported quantities in this family: 1, 2, 3, 5, 10. Counts and units must be matched to the exact listing.

Compare the exact selection

Choose the labeled amount per unit and quantity before comparing. A single unit and a multipack have different upfront prices. Keep product format and exact recipe consistent; similar names do not establish equivalent products.

Follow the original listing to check its quantity, availability and current price. Unit prices use the full labeled mass in each selection.

Single-vial price overview

Compare within each strength. Every row covers one vial and includes only listings marked in stock with known quantities.

Listed total prices before additional promotions or coupon estimates. Includes supplier captures and aggregator reports; capture dates do not confirm current vendor price or stock. Shipping and tax extra. Open the source before relying on a price.
StrengthSelectionLowest listed total pricePrice per mgSupplier countCompare
2 mg1 vial$45.00$22.501Compare
5 mg1 vial$29.99$6.0015Compare
10 mg1 vial$35.10$3.5120Compare
13 mg1 vial$62.50$4.811Compare

Suppliers with Sermorelin listings

32 profiles
View 26 more supplier profiles

Sources and comparison limits

4 listings from direct supplier captures and 41 listings from aggregator reports. Capture and import dates record when data was obtained; they do not guarantee the supplier’s current price or stock.

Listings include out-of-stock and unconfirmed-stock records. Inclusion does not certify a supplier, a batch or a product. Read how matching and source dates work.

Explore more vial listings

BPC-157GHK-CuMOTS-cIpamorelinNAD+Tesamorelin

Browse all products

FROM PEPTIDES CALCULATOR

About Sermorelin

Source profile reviewed 2026-10-01 · Imported 2026-10-22. Read the full compound profile

Sermorelin is the first 29 amino acids of human growth hormone-releasing hormone with a C-terminal amide, the shortest fragment that keeps essentially all of the activity of the full 44-residue hormone. It stimulates the pituitary to release its own growth hormone rather than supplying growth hormone directly, which leaves the somatostatin feedback loop intact. EMD Serono sold it as Geref for treating idiopathic growth hormone deficiency in children and as Geref Diagnostic for pituitary testing; both were discontinued in 2008 for commercial reasons, and the FDA determined in 2013 that neither had been withdrawn for safety or effectiveness. There is now no approved sermorelin product in the United States or the European Union, and all current adult use is off-label prescribing of compounded material for body composition, sleep and longevity, none of which has been tested in a controlled trial.

Formula
C149 H246 N44 O42 S
Molar mass
3,357.9 g/mol
CAS number
86168-78-7
Amino acids
29

Research evidence described in the source

Human

Historical pediatric clinical data

Daily 30 mcg/kg studies reported increased growth velocity in some prepubertal children.

Review

Diagnostic and treatment review

The evidence base is old, indication-specific, and does not establish final-height superiority.

Human

Limited older-adult studies

Small studies measured endocrine and body-composition biomarkers rather than long-term clinical outcomes.

Limitations noted in the source

  • The former approved product was discontinued; compounded preparations differ in oversight.
  • Pediatric weight-based evidence does not validate fixed adult wellness doses.
  • A calculator preset is a recorded research convention, not a recommendation or evidence of clinical benefit.
  • Identity, purity, sterility, and stability can vary substantially outside regulated manufacturing.
Publications and references linked by the source

Background is reproduced from Peptides Calculator with attribution. The source describes compound-level research. It does not evaluate the identity, quality or suitability of a listed supplier’s product or batch.